Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis
- 5 December 2015
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Vaccines
- Vol. 15 (2), 173-187
- https://doi.org/10.1586/14760584.2016.1115353
Abstract
Respiratory syncytial virus (RSV) is the most important cause of lower respiratory tract infections causing bronchiolitis and some mortality in young children and the elderly. Despite decades of re...Keywords
Funding Information
- Georgia Research Alliance
This publication has 102 references indexed in Scilit:
- Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthmaNature Medicine, 2012
- Aging and Immune Function: Molecular Mechanisms to InterventionsAntioxidants and Redox Signaling, 2011
- The cotton rat model of respiratory viral infectionsBiologicals, 2009
- Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab′)2 components mediates reduced pulmonary inflammation in miceJournal of General Virology, 2009
- Safety and efficacy of neonatal vaccinationEuropean Journal of Immunology, 2009
- Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCGProceedings of the National Academy of Sciences of the United States of America, 2008
- Vaccines: Correlates of Vaccine‐Induced ImmunityClinical Infectious Diseases, 2008
- Structure and ion channel activity of the human respiratory syncytial virus (hRSV) small hydrophobic protein transmembrane domainProtein Science, 2008
- Pretreatment with Recombinant Human Vascular Endothelial Growth Factor Reduces Virus Replication and Inflammation in a Perinatal Lamb Model of Respiratory Syncytial Virus InfectionViral Immunology, 2007
- Neurotrophin-regulated signalling pathwaysPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2006